271 related articles for article (PubMed ID: 14680420)
21. Novel antipsychotic use in schizophrenia.
J Clin Psychiatry; 2000 Mar; 61(3):223-32. PubMed ID: 10841660
[No Abstract] [Full Text] [Related]
22. Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol.
Kongsakon R; Leelahanaj T; Price N; Birinyi-Strachan L; Davey P
J Med Assoc Thai; 2005 Sep; 88(9):1267-77. PubMed ID: 16536115
[TBL] [Abstract][Full Text] [Related]
23. Pharmacologic treatment of schizophrenia.
Kane JM
Biol Psychiatry; 1999 Nov; 46(10):1396-408. PubMed ID: 10578454
[TBL] [Abstract][Full Text] [Related]
24. Did CATIE influence antipsychotic use?
Citrome L; Jaffe A; Martello D; Allingham B; Levine J
Psychiatr Serv; 2008 May; 59(5):476. PubMed ID: 18451000
[No Abstract] [Full Text] [Related]
25. Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses.
Zedkova I; Dudova I; Urbanek T; Hrdlicka M
Neuro Endocrinol Lett; 2011; 32(5):667-70. PubMed ID: 22167144
[TBL] [Abstract][Full Text] [Related]
26. Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents.
Kelleher JP; Centorrino F; Albert MJ; Baldessarini RJ
CNS Drugs; 2002; 16(4):249-61. PubMed ID: 11945108
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological approaches to the management of schizophrenia.
Lambert TJ; Castle DJ
Med J Aust; 2003 May; 178(S9):S57-61. PubMed ID: 12720524
[TBL] [Abstract][Full Text] [Related]
28. Clozapine: a comparison with other novel antipsychotics.
Fleischhacker WW
J Clin Psychiatry; 1999; 60 Suppl 12():30-4. PubMed ID: 10372608
[TBL] [Abstract][Full Text] [Related]
29. The impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on prescribing practices: an analysis of data from a large midwestern state.
Berkowitz RL; Patel U; Ni Q; Parks JJ; Docherty JP
J Clin Psychiatry; 2012 Apr; 73(4):498-503. PubMed ID: 22226332
[TBL] [Abstract][Full Text] [Related]
30. Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.
Goikolea JM; Colom F; Torres I; Capapey J; Valentà M; Undurraga J; Grande I; Sanchez-Moreno J; Vieta E
J Affect Disord; 2013 Jan; 144(3):191-8. PubMed ID: 23089129
[TBL] [Abstract][Full Text] [Related]
31. Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials.
Stahl SM
J Clin Psychiatry; 1999; 60 Suppl 10():31-41. PubMed ID: 10340685
[TBL] [Abstract][Full Text] [Related]
32. Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions.
Raggi MA; Mandrioli R; Sabbioni C; Pucci V
Curr Med Chem; 2004 Feb; 11(3):279-96. PubMed ID: 14965232
[TBL] [Abstract][Full Text] [Related]
33. Atypical antipsychotics for the treatment of disruptive behavior.
Lohr WD; Honaker J
Pediatr Ann; 2013 Feb; 42(2):72-7. PubMed ID: 23379410
[No Abstract] [Full Text] [Related]
34. The case for atypical antipsychotics in bipolar disorder.
Shattell M; Keltner NL
Perspect Psychiatr Care; 2004; 40(1):34-8. PubMed ID: 15147051
[TBL] [Abstract][Full Text] [Related]
35. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
McDougle CJ; Stigler KA; Erickson CA; Posey DJ
J Clin Psychiatry; 2008; 69 Suppl 4():15-20. PubMed ID: 18533764
[TBL] [Abstract][Full Text] [Related]
36. The role of atypical antipsychotics in the treatment of delirium.
Schwartz TL; Masand PS
Psychosomatics; 2002; 43(3):171-4. PubMed ID: 12075031
[TBL] [Abstract][Full Text] [Related]
37. The new antipsychotic compounds: is a clinical choice algorithm possible?
Wirshing WC
West J Med; 1998 Jul; 169(1):43-4. PubMed ID: 9682633
[No Abstract] [Full Text] [Related]
38. Atypical antipsychotics: matching receptor profile to individual patient's clinical profile.
Shayegan DK; Stahl SM
CNS Spectr; 2004 Oct; 9(10 Suppl 11):6-14. PubMed ID: 15475871
[TBL] [Abstract][Full Text] [Related]
39. Measuring outcome in schizophrenia: differences among the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry; 1998; 59 Suppl 12():3-9. PubMed ID: 9766613
[TBL] [Abstract][Full Text] [Related]
40. Managing the acutely agitated and psychotic patient.
Nordstrom K; Allen MH
CNS Spectr; 2007 Oct; 12(10 Suppl 17):5-11. PubMed ID: 17934384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
